Literature DB >> 8578442

Platelet activation: signal transduction via membrane receptors.

K J Clemetson1.   

Abstract

The first stage in signal transduction in platelets is interaction between the agonist (or adhesive protein) and its receptor. Changes in conformation or clustering induced by binding activate signalling on the cytoplasmic side of the platelet membrane. Platelets contain several families of receptors such as the leucine rich repeat group, GPIb-V-IX, involved in adhesion to von Willebrand factor and modulation of the thrombin response. Platelet integrins include GPIIb-IIIa (alpha IIb beta 3), the receptor for fibrinogen and the major mediator of aggregation, which is also a critical signal transducer both inside-out and outside-in to modulate primary signals. Molecules implicated as collagen receptors include the integrin alpha 2 beta 1, CD36 and GPVI and involve a novel signalling pathway. Many seven transmembrane receptors have been identified; current interest is in the proteolytic and purinergic families.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578442

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Inhibition of human platelet adenylate cyclase activity by adrenaline, thrombin and collagen: analysis and reinterpretation of experimental data.

Authors:  A Juska; R W Farndale
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Disaggregation of aggregated platelets by apyrase from the tick, Ornithodoros savignyi (Acari: Argasidae).

Authors:  B J Mans; J Coetzee; A I Louw; A R Gaspar; A W Neitz
Journal:  Exp Appl Acarol       Date:  2000-04       Impact factor: 2.132

3.  Activation of blood platelets in echinococcosis--CD62P and CD63 expression.

Authors:  Joanna Matowicka-Karna; Halina Kemona; Violetta Dymicka-Piekarska; Anna Butkiewicz
Journal:  Parasitol Res       Date:  2005-12-07       Impact factor: 2.289

Review 4.  Platelet "first responders" in wound response, cancer, and metastasis.

Authors:  David G Menter; Scott Kopetz; Ernest Hawk; Anil K Sood; Jonathan M Loree; Paolo Gresele; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

5.  Cloning, expression, and hemostatic activities of a disintegrin, r-mojastin 1, from the mohave rattlesnake (Crotalus scutulatus scutulatus).

Authors:  Elda E Sánchez; Sara E Lucena; Steven Reyes; Julio G Soto; Esteban Cantu; Juan Carlos Lopez-Johnston; Belsy Guerrero; Ana Maria Salazar; Alexis Rodríguez-Acosta; Jacob A Galán; W Andy Tao; John C Pérez
Journal:  Thromb Res       Date:  2010-07-02       Impact factor: 3.944

6.  Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.

Authors:  T Ohmori; Y Yatomi; N Asazuma; K Satoh; Y Ozaki
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 7.  Current developments in anti-platelet therapy.

Authors:  Florian B Mayr; Bernd Jilma
Journal:  Wien Med Wochenschr       Date:  2006-09

8.  Effects of TRA-418, a novel TP-receptor antagonist, and IP-receptor agonist, on human platelet activation and aggregation.

Authors:  Mitsuko Miyamoto; Naohiro Yamada; Shiho Ikezawa; Michihiro Ohno; Atsushi Otake; Kazuo Umemura; Teruo Matsushita
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

Review 9.  Antiplatelet therapy in cardiovascular disease.

Authors:  M W H Behan; R F Storey
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

Review 10.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.